PMA filing checklist
This article was originally published in The Gray Sheet
Executive Summary
Financial disclosure requirements for clinical investigators (21 CFR 54) must be met for CDRH to file a premarket application, updated "1Checklist for Filing Decision for PMAs" specifies. Posted on the agency's website Jan. 24, the document also notes that environmental assessment under 21 CFR 25.20(n) is limited to first of a kind devices. Copies of key articles referenced in bibliographic sections should be submitted to FDA in English...
You may also be interested in...
Regulatory News In Brief
FDAMA six-year rule: Provision allowing information from a PMA submission, six years after approval, to be applied in support of other PMA decisions "conceivably...could be used in biocompatibility" tests, CDRH Director David Feigal notes at a Jan. 31 National Forum on Biomedical Imaging in Oncology meeting. Safety and effectiveness data from six-year-old PMAs may be "sort of like an automatic cross reference," Feigal said. The option will be available in two years...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.